Streetbeat News

Regulatory

BABA

Alibaba Group Holding Limited (NYSE:BABA) stock is trading lower due to concerns about China's economic recovery and fresh U.S. semiconductor technology sanctions. However, Alibaba co-founder Joe Tsai highlighted the significant role of Alibaba Cloud in the operations of Chinese tech firms and the country's AI development. Alibaba Cloud unveiled Tongyi Qianwen 2.0, the latest version of its AI large language model.

Portfolio Pulse from Anusuya Lahiri

November 01, 2023 | 1:29 pm

EH

EHang Holdings Limited (NASDAQ:EH) has inaugurated its first European Urban Air Mobility (UAM) Center in Spain. The center, located at the Lleida–Alguaire International Airport, is the first of its kind in Europe for unmanned electric vertical take-off and landing (eVTOL) aircraft. The center is a result of a collaboration between EHang and Aeroports de Catalunya. The UAM Center includes a vertiport that complies with EASA's design criteria and will enable seamless incorporation with the airport terminal, platform, control tower, equipment, procedures, and regulations.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 1:29 pm

JCSE

JE Cleantech Holdings Limited (NASDAQ:JCSE), a Singapore-based cleantech company, has regained compliance with the Nasdaq minimum bid price requirement. The company initiated a 1-for-3 Share Consolidation, reducing the total number of authorized Ordinary Shares from 15,020,000 to 5,006,666 and increasing the par value per share. Following this, the daily closing bid price of the company's shares remained above $1.00 for ten consecutive business days, bringing the company back into compliance with Nasdaq listing standards.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 1:26 pm

TTOO

T2 Biosystems has regained compliance with Nasdaq's listing requirements, potentially avoiding delisting.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 1:17 pm

CWBR

CohBar's board has determined that there is no viable path forward to consummate a merger, primarily due to oral guidance received from Nasdaq, according to an SEC 8K filing.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 1:13 pm

JAGX

Jaguar Health (NASDAQ:JAGX) has been granted a new U.S. patent for methods of treating short bowel syndrome (SBS), bile acid diarrhea, and diarrhea associated with small intestine resection or gallbladder removal, using crofelemer, a novel plant-based prescription drug. The company is supporting studies of crofelemer for SBS and microvillus inclusion disease (MVID) in the US, EU, and Middle East/North Africa regions, with results expected by the end of 2023 and in 2024. Crofelemer has been granted Orphan Drug Designation (ODD) by the FDA and the European Medicines Agency for both MVID and SBS with intestinal failure.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:44 pm

HSBC

RGTI

Rigetti UK Limited, a subsidiary of Rigetti Computing, Inc. (NASDAQ:RGTI), has been awarded an Innovate UK grant to enhance quantum machine learning methods for anti-money laundering detection. The consortium, which includes HSBC, the Quantum Software Lab at the University of Edinburgh, and the National Quantum Computing Centre, aims to improve current machine learning algorithms. The project, which began on September 1, 2023, will last 18 months.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:40 pm

IPX

IperionX Limited (NASDAQ:IPX) has been awarded a $12.7 million grant by the U.S. Department of Defense (DoD) to address U.S. titanium supply chain vulnerabilities. The grant, along with a potential $11.5 million in equipment financing from the Export-Import Bank of the United States, will be used to accelerate the development of a titanium production facility in Halifax County, Virginia. The U.S. currently imports over 95% of the titanium sponge required for the defense sector. IperionX aims to reduce this reliance by reshoring a full titanium supply chain to the U.S.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:37 pm

ZVSA

ZyVersa Therapeutics (NASDAQ:ZVSA) has announced a publication in Molecular Neurobiology that reinforces data showing that its Inflammasome ASC Inhibitor IC 100 can attenuate the inflammatory response causing neuronal damage in a multiple sclerosis model. The study demonstrated that NLRP3 inflammasomes play a significant role in the pathogenesis of multiple sclerosis, and that their inhibition can lead to significant decreases in neuronal damage and demyelination. ZyVersa is developing IC 100 to inhibit the formation of multiple types of inflammasomes and their associated ASC specks to attenuate damaging inflammation.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:26 pm

SLE

Super League Enterprises (NASDAQ:SLE) has been granted a new patent by the United States Patent and Trademark Office (USPTO) for AI-driven optimization of live streaming content. The patent pertains to the production and intelligent prioritization of simultaneous perspectives within virtual environments, particularly video games. The company's creative studio has been a significant contributor to its business, producing content for brands like MTV and Samsung.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 12:19 pm